Adrenomedullin Gene Transfer Induces Therapeutic Angiogenesis in a Rabbit Model of Chronic Hind Limb Ischemia
- 3 February 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (4), 526-531
- https://doi.org/10.1161/01.cir.0000109700.81266.32
Abstract
Background— Earlier studies have shown that adrenomedullin (AM), a potent vasodilator peptide, has a variety of cardiovascular effects. However, whether AM has angiogenic potential remains unknown. This study investigated whether AM gene transfer induces therapeutic angiogenesis in chronic hind limb ischemia. Methods and Results— Ischemia was induced in the hind limb of 21 Japanese White rabbits. Positively charged biodegradable gelatin was used to produce ionically linked DNA-gelatin complexes that could delay DNA degradation. Human AM DNA (naked AM group), AM DNA-gelatin complex (AM-gelatin group), or gelatin alone (control group) was injected into the ischemic thigh muscles. Four weeks after gene transfer, significant improvements in collateral formation and hind limb perfusion were observed in the naked AM group and AM-gelatin group compared with the control group (calf blood pressure ratio: 0.60±0.02, 0.72±0.03, 0.42±0.06, respectively). Interestingly, hind limb perfusion and capillary density of ischemic muscles were highest in the AM-gelatin group, which revealed the highest content of AM in the muscles among the three groups. As a result, necrosis of lower hind limb and thigh muscles was minimal in the AM-gelatin group. Conclusions— AM gene transfer induced therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia. Furthermore, the use of biodegradable gelatin as a nonviral vector augmented AM expression and thereby enhanced the therapeutic effects of AM gene transfer. Thus, gelatin-mediated AM gene transfer may be a new therapeutic strategy for the treatment of peripheral vascular diseases.Keywords
This publication has 19 references indexed in Scilit:
- Hybrid Cell–Gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor CellsCirculation, 2003
- Evidence for the Physiological and Pathological Roles of Adrenomedullin from Genetic Engineering in MiceAnnals of the New York Academy of Sciences, 2001
- Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin geneProceedings of the National Academy of Sciences, 2001
- Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cellsJournal Of Hypertension, 1996
- Receptors for adrenomedullin in human vascular endothelial cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Production and Secretion of Adrenomedullin from Vascular Smooth-Muscle Cells: Augmented Production by Tumor Necrosis Factor-αBiochemical and Biophysical Research Communications, 1994
- Endothelial Cells Actively Synthesize and Secrete AdrenomedullinBiochemical and Biophysical Research Communications, 1994
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.JCI Insight, 1994
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993
- Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheresJournal of Pharmacy and Pharmacology, 1987